Literature DB >> 16317163

Nutrient-gene interaction: metabolic genotype-phenotype relationship.

Vay Liang W Go1, Christine T H Nguyen, Diane M Harris, Wai-Nang Paul Lee.   

Abstract

The U.S. Department of Health and Human Services (DHHS)/USDA Dietary Guidelines for Americans is a science and population evidence-based guide on diet and physical activity, providing advice and recommendations to promote a healthier lifestyle and reduce the risk of chronic diseases, including cancer. These recommendations are supported by the comprehensive evidence-based review on diet and cancer prevention conducted by the American Institute for Cancer Research, National Cancer Institute, World Health Organization/International Agency for Research on Cancer, and others. However, influencing dietary effects are the individual genetic predispositions that are the basis for considerable interindividual variations in cancer risk within the population and in nutrient homeostasis, which is maintained by genomic-nutrient and metabolic-phenotype interactions. Although genetics is an important component, it accounts for only a portion of this variation. An individual's overall phenotype, including health status, is achieved and maintained by the sum of metabolic activities functioning under differing circumstances within the life cycle and the complex interactions among genotype, metabolic phenotype, and the environment. In this postgenomic era, high-throughput groups of technologies in genomics, proteomics, and metabolomics measure and analyze DNA sequences, RNA transcripts, proteins, and nutrient-metabolic fluxes in a single experiment. These advances have transformed biomarker studies on nutrient-gene interactions from a reductionist concept into a holistic practice in which many regulated genes involved in metabolism, along with its metabolic phenotypes, can be measured through functional genomics and metabolic profiling. The overall integration of data and information from the building blocks of metabolism-based nutrient-gene interaction can lead to future individualized dietary recommendations to diminish cancer risk.

Entities:  

Mesh:

Year:  2005        PMID: 16317163     DOI: 10.1093/jn/135.12.3016S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  15 in total

1.  Nutritionally improved agricultural crops.

Authors:  Martina Newell-McGloughlin
Journal:  Plant Physiol       Date:  2008-07       Impact factor: 8.340

2.  The marriage of nutrigenomics with the microbiome: the case of infant-associated bifidobacteria and milk.

Authors:  David A Sela; David A Mills
Journal:  Am J Clin Nutr       Date:  2014-01-22       Impact factor: 7.045

3.  Circulating metabolite profiles to predict overall survival in advanced non-small cell lung cancer patients receiving first-line chemotherapy.

Authors:  Jie Shen; Yuanqing Ye; David W Chang; Maosheng Huang; John V Heymach; Jack A Roth; Xifeng Wu; Hua Zhao
Journal:  Lung Cancer       Date:  2017-11-02       Impact factor: 5.705

4.  The importance and future of biochemical engineering.

Authors:  Timothy A Whitehead; Scott Banta; William E Bentley; Michael J Betenbaugh; Christina Chan; Douglas S Clark; Corinne A Hoesli; Michael C Jewett; Beth Junker; Mattheos Koffas; Rashmi Kshirsagar; Amanda Lewis; Chien-Ting Li; Costas Maranas; E Terry Papoutsakis; Kristala L J Prather; Steffen Schaffer; Laura Segatori; Ian Wheeldon
Journal:  Biotechnol Bioeng       Date:  2020-05-29       Impact factor: 4.530

5.  Diverse mechanisms of growth inhibition by luteolin, resveratrol, and quercetin in MIA PaCa-2 cells: a comparative glucose tracer study with the fatty acid synthase inhibitor C75.

Authors:  Diane M Harris; Luyi Li; Monica Chen; F Tracy Lagunero; Vay Liang W Go; Laszlo G Boros
Journal:  Metabolomics       Date:  2011-03-25       Impact factor: 4.290

Review 6.  The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and Epigenome.

Authors:  Yiwei Li; Vay Liang W Go; Fazlul H Sarkar
Journal:  Pancreas       Date:  2015-01       Impact factor: 3.327

7.  Plasma metabolomic profiles in breast cancer patients and healthy controls: by race and tumor receptor subtypes.

Authors:  Jie Shen; Li Yan; Song Liu; Christine B Ambrosone; Hua Zhao
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

8.  Genetic variants at the PDZ-interacting domain of the scavenger receptor class B type I interact with diet to influence the risk of metabolic syndrome in obese men and women.

Authors:  Mireia Junyent; Donna K Arnett; Michael Y Tsai; Edmond K Kabagambe; Robert J Straka; Michael Province; Ping An; Chao-Qiang Lai; Laurence D Parnell; Jian Shen; Yu-Chi Lee; Ingrid Borecki; Jose M Ordovás
Journal:  J Nutr       Date:  2009-03-25       Impact factor: 4.798

9.  From evidence-based medicine to genomic medicine.

Authors:  Dhavendra Kumar
Journal:  Genomic Med       Date:  2007-12-18

10.  A chain reaction approach to modelling gene pathways.

Authors:  Gary C Cheng; Dung-Tsa Chen; James J Chen; Seng-Jaw Soong; Coral Lamartiniere; Stephen Barnes
Journal:  Transl Cancer Res       Date:  2012-05-31       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.